[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity

Rhea-AI Filing Summary

United Therapeutics (UTHR) disclosed an insider update: a director filed a Form 4 noting a transfer of 225 shares of common stock on 09/09/2024 from a jointly held account to an account in which he has no beneficial interest. The entry shows Transaction Code G at a reported price of $0.00.

The filing states the transfer was done without the reporting person’s knowledge and was discovered recently, which caused subsequent Forms 4 to overstate his beneficial holdings. Following the correction, the director reports 4,640 shares held directly.

Insights

Securities compliance analyst

Routine insider correction; no cash consideration reported.

This Form 4 records a 225-share transfer on 09/09/2024 coded G, with a reported price of $0.00. Code G typically denotes a bona fide gift or similar transfer without consideration. The filer indicates the transfer was discovered recently and that later Forms 4 had overstated holdings.

Post-update, the director lists 4,640 shares held directly. There is no issuer cash flow in this entry and no change to company operations is implied. The impact is administrative; actual market effects depend on whether any future transactions are reported.

Insider Trade Summary

225 shares gifted

Mixed 1 txn

Insider CAUSEY CHRISTOPHER

Role Director

Type	Security	Shares	Price	Value
Gift	Common Stock	225	$0.00	--

Holdings After Transaction: Common Stock — 4,640 shares (Direct)

Footnotes (1)

1. This Form 4 reports the transfer of 225 shares of common stock on September 9, 2024, from an account jointly held by the reporting person and his son, to an account in which the reporting person has no beneficial interest. This transfer was done without the knowledge of the reporting person, and was discovered recently. As a result of this omission, the amounts of securities beneficially owned reported in subsequent Forms 4 by the reporting person were overstated. Total reported as of the date of filing, and takes into account transactions that have occurred following the date of the original transaction reported on this Form 4.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CAUSEY CHRISTOPHER

(Last) (First) (Middle)

C/O UNITED THERAPEUTICS CORPORATION

1000 SPRING STREET

(Street)

SILVER SPRING MD 20910

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [ UTHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2024(1)		G		225	D	$0.00	4,640(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This Form 4 reports the transfer of 225 shares of common stock on September 9, 2024, from an account jointly held by the reporting person and his son, to an account in which the reporting person has no beneficial interest. This transfer was done without the knowledge of the reporting person, and was discovered recently. As a result of this omission, the amounts of securities beneficially owned reported in subsequent Forms 4 by the reporting person were overstated.

2. Total reported as of the date of filing, and takes into account transactions that have occurred following the date of the original transaction reported on this Form 4.

Remarks:

	/s/ John S. Hess, Jr. under Power of Attorney	10/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.